Literature DB >> 8740587

Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.

T Nakagawa1, T Kubota, M Kabuto, N Fujimoto, Y Okada.   

Abstract

Human glioma cells (T98G and A172 cell lines) were cultured on various extracellular matrix (ECM) components including type I, IV and V collagens, fibronectin, laminin, and reconstituted basement membrane (Matrigel), and the role of matrix metalloproteinases (MMPs) in their growth and invasion was examined. T98G glioma cells grew well on these ECM components and invaded the reconstituted basement membrane. In contrast, A172 glioma cells showed growth inhibition on collagen types IV and V and Matrigel without invasion of the Matrigel. Gelatin zymography and enzyme immunoassays demonstrated that T98G glioma cells, but not A172 cells, secrete a large amount of matrix metalloproteinase-2 (MMP-2, 72 kD gelatinase/type IV collagenase = gelatinase A), and this was confirmed by immunoblotting and immunohistochemistry. Of the two different tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2), T98G cells produced only TIMP-1 during culture on Matrigel, whereas A172 cells secreted both. Although both human recombinant TIMP-1 and TIMP-2 stimulated T98G cell growth slightly on Matrigel, the in vitro invasiveness was significantly reduced by only recombinant TIMP-2. These results suggest that MMP-2 plays an important role in the ECM invasion of T98G human glioma cells in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8740587     DOI: 10.1007/bf00300442

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  47 in total

1.  C6 glioma-astrocytoma cell and fetal astrocyte migration into artificial basement membrane: a permissive substrate for neural tumors but not fetal astrocytes.

Authors:  J J Bernstein; E R Laws; K V Levine; L R Wood; G Tadvalkar; W J Goldberg
Journal:  Neurosurgery       Date:  1991-05       Impact factor: 4.654

2.  Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

Authors:  O A Alvarez; D F Carmichael; Y A DeClerck
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

Review 3.  Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Authors:  J S Rao; P A Steck; P Tofilon; D Boyd; F Ali-Osman; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

Authors:  M S Hibbs; K A Hasty; J M Seyer; A H Kang; C L Mainardi
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

5.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.

Authors:  D F Carmichael; A Sommer; R C Thompson; D C Anderson; C G Smith; H G Welgus; G P Stricklin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Invasion of extracellular matrix by cultured colon cancer cells: dependence on urokinase receptor display.

Authors:  W Schlechte; M Brattain; D Boyd
Journal:  Cancer Commun       Date:  1990

7.  Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2.

Authors:  G I Goldberg; B L Marmer; G A Grant; A Z Eisen; S Wilhelm; C S He
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

8.  Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Authors:  J S Rao; P A Steck; S Mohanam; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

9.  CD44 mediates human glioma cell adhesion and invasion in vitro.

Authors:  A Merzak; S Koocheckpour; G J Pilkington
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

10.  Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloprotease.

Authors:  P A Paganetti; P Caroni; M E Schwab
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  13 in total

Review 1.  Multi-agent cytostatic treatment of 'low-grade' gliomas.

Authors:  M E Linskey
Journal:  Curr Oncol Rep       Date:  2000-09       Impact factor: 5.075

Review 2.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 3.  Anti-angiogenic treatment strategies for malignant brain tumors.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: response to soluble and extracellular matrix-bound tumor necrosis factor-alpha.

Authors:  G Astrid Limb; Julie T Daniels; Robert Pleass; David G Charteris; Philip J Luthert; Peng T Khaw
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms.

Authors:  J Jäälinojä; R Herva; M Korpela; M Höyhtyä; T Turpeenniemi-Hujanen
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

6.  The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells.

Authors:  T Kodera; T Nakagawa; T Kubota; M Kabuto; K Sato; H Kobayashi
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

7.  Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2.

Authors:  Rosalyn Ram; Gustavo Lorente; Karoly Nikolich; Roman Urfer; Erik Foehr; Usha Nagavarapu
Journal:  J Neurooncol       Date:  2006-02       Impact factor: 4.130

8.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Authors:  M Nakada; H Nakamura; E Ikeda; N Fujimoto; J Yamashita; H Sato; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

9.  Matrix metalloproteinase-2 and matrix metalloproteinase-9 expressions correlate with the recurrence of intracranial meningiomas.

Authors:  Masaki Okada; Keisuke Miyake; Yoshihito Matsumoto; Nobuyuki Kawai; Katsuzo Kunishio; Seigo Nagao
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

10.  Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action.

Authors:  Annielle Mendes Brito da Silva; Laíz Costa Silva-Gonçalves; Fernando Augusto Oliveira; Manoel Arcisio-Miranda
Journal:  Mol Neurobiol       Date:  2017-09-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.